Aotearoa behind in funding modern medicines - specialists

Sick New zealanders are missing out top clinical drug trials because Aotearoa is already behind the pack when it comes to funding modern medicines, according some specialists. Many trials require would be participants to have access to what's known as "standard of care drugs", that's the best available medicines, to provide a comparison to the trial drug. A 2022 to 2023 Medicines New Zealand report said Aotearoa is on average twice as slow to publicly fund modern medicines as comparable countries, Haematologist Dr Rodger Tiedemann spoke to Lisa Owen.